Flow Traders BV (FLOW)
Euronext Amsterdam · Netherlands · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 25.54 |
|---|---|
| 52-week range | 22.10 – 30.48 |
| Return, 1 month / 3 months | −9.9% / −3.2% |
| Return, 1 year / 3 years | −1.1% / +57.2% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 26.3% |
| Worst drawdown (1 year) | -20.2% |
| Average daily value traded | 2.54M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Flow Traders is a proprietary trading firm based in Amsterdam that acts as a market maker, chiefly in exchange-traded products such as exchange-traded funds. It quotes prices on exchanges around the world, providing liquidity to other market participants and earning income from the difference between the prices at which it buys and sells. Its counterparties include institutional investors and other trading firms that need to trade these products quickly and in size.
On this site Flow Traders BV appears as a stock on the Euronext Amsterdam (Netherlands), code FLOW, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Flow Traders BV (FLOW) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 25.54 on 22 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 57 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.1% and over the last three months it fell 3.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.8% | ||
| From 52-week high | -15.8% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.2% | ||
| 6-month return | -8.5% | ||
| 12-month return, skipping the last month | 9.8% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.2% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.54M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.6% |
|---|---|
| 1 month | −9.9% |
| 3 months | −3.2% |
| 6 months | −8.5% |
| 1 year | −1.1% |
| 3 years | +57.2% |
| 5 years | −20.2% |
Signals
| 50-day / 200-day average | 27.46 / 27.10 |
|---|---|
| Golden / death cross (60 days) | Golden, 42 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.54 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Jun 2024 | EUR 0.1500 |
| 15 Aug 2023 | EUR 0.3000 |
| 28 Apr 2023 | EUR 0.8000 |
| 16 Aug 2022 | EUR 0.7000 |
| 3 May 2022 | EUR 0.3500 |
| 17 Aug 2021 | EUR 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.